Nonclinical Study. Zosano will complete a 30-day systemic toxicology study in rats prior to submission of the NDA to the FDA.
Appears in 2 contracts
Sources: Collaboration, Development and License Agreement (Zosano Pharma Corp), Collaboration, Development and License Agreement (Zosano Pharma Corp)